Grade 1 and grade 2 meningiomas differ in a growth signal protein
Original title: Differential expression of TGF-β1, TGF-β2, and TGF-β3 across WHO grades in meningioma: convergent evidence from mRNA, methylation, miRNA, and protein analysis.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was done on cells in a lab, not in people. It is a very early step.
This was lab testing on tumor samples, not a treatment tried in people.
The short version
Tumor samples showed chemical differences between grade 1 and grade 2 meningiomas.
What was studied. Doctors at two hospitals studied tumor tissue from 154 people who had meningioma surgery. Of those, 124 had grade 1 tumors and 30 had grade 2 tumors. The team measured a protein family called TGF-beta and the signals that control it.
What they found. Grade 2 tumors had more TGF-beta 2 and TGF-beta 3 than grade 1 tumors. The same tumors had much less TGF-beta 1, which the team did not expect. All six of the small control molecules they checked were lower in grade 2 tumors.
What this means, and what it doesn't
What it could mean: These patterns may one day help doctors tell tumor grades apart. They could become markers that describe a tumor more clearly. They do not change care for anyone today.
What it doesn't mean: This is early lab work on tumor tissue that was already removed. No drug or treatment was tested in this study. It does not mean a new treatment is close, and it is not a cure. Much more work is needed before this could reach the clinic.
Source: PubMed, August 17, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.